05/06/2025
6:05 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
6:30 AM | Beam Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/10/2025
8:36 AM | Beam Therapeutics (Issuer)
FMR LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2025
8:50 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
8:50 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
8:51 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
8:52 PM | Beam Therapeutics (Issuer)
Evans John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
8:53 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
6:11 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
6:13 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
6:18 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BEAM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Beam Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/02/2025
6:21 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
6:10 PM | Beam Therapeutics (Issuer)
Evans John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
10:02 AM | Beam Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
03/31/2025
5:43 PM | Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/31/2025
5:43 PM | Beam Therapeutics (Subject)
Bellon Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/31/2025
5:43 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/31/2025
5:44 PM | Beam Therapeutics (Subject)
Simon Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
4:23 PM | Beam Therapeutics (Filer)
| Form 424B5 | |
03/10/2025
4:02 PM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2025
5:10 AM | Beam Therapeutics (Filer)
| Form 424B5 | |
03/10/2025
5:13 AM | Beam Therapeutics (Subject)
| Form FWP | |
03/10/2025
5:06 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
6:51 AM | Beam Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2025
6:30 AM | Beam Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2025
6:19 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
3:10 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:30 PM | Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
3:05 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:05 PM | Beam Therapeutics (Issuer)
Evans John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:05 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:05 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:05 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
3:12 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:05 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:46 PM | ARK Investment Management LLC (Filed by)
Beam Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/06/2025
4:48 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:49 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
7:04 PM | Beam Therapeutics (Issuer)
Emany Sravan Kumar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
6:26 PM | Beam Therapeutics (Subject)
Bellon Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/30/2024
6:29 PM | Beam Therapeutics (Subject)
Cavanagh Bethany J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The #1 AI Energy Stock (Ad) Nearly $600 billion is projected to be spent on AI data centers this year.
That's because the ones being built now will dwarf everything that came before them.
Thanks to AI's ravenous hunger for power …
They are beginning to morph into sprawling behemoths. Click here to learn more about the #1 AI Energy Stock of 2025 |
12/19/2024
3:10 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
6:01 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
6:06 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
6:18 AM | Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/04/2024
6:22 AM | Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
6:08 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:10 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
8:56 AM | Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
11/05/2024
8:00 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
8:06 AM | Beam Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
7:30 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
6:05 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
10:50 AM | Beam Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024
3:44 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
10:37 AM | Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2024
4:00 PM | Beam Therapeutics (Subject)
Burrell Terry-Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
4:51 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:52 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:49 PM | Beam Therapeutics (Issuer)
Evans John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:51 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:15 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/06/2024
6:08 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
6:01 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
